Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.48 |
| ▸ | LTA4H | P09960 | 2/20 | 0.47 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.47 |
| ▸ | LAP3 | P28838 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ALPI | P09923 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1840095 | 1.00 | ALDH1A1 (0.50) | ALDH1A1IDO1KMT2AMAPK1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL27309456 | 0.98 | ALDH1A1 (0.49) | ALDH1A1IDO1KMT2AMAPK1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL27309455 | 0.98 | ALDH1A1 (0.49) | ALDH1A1IDO1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL8618286 | 0.90 | ALDH1A1 (0.47) | ALDH1A1IDO1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL8618298 | 0.90 | ALDH1A1 (0.47) | ALDH1A1IDO1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL22455043 | 0.90 | ALDH1A1 (0.47) | ALDH1A1IDO1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL8618076 | 0.89 | DPP8 (0.47) | ALDH1A1IDO1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL8618084 | 0.89 | DPP8 (0.47) | ALDH1A1IDO1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL4161005 | 0.88 | IDO1 (0.53) | ALDH1A1IDO1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL10441465 | 0.88 | IDO1 (0.53) | ALDH1A1IDO1KMT2AMAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7799762-B2 | Acyl pseudodipeptides which carry a functionalised auxialiary arm | OM PHARMA (CH) | 2010-09-21 | — | — | US | claimed |
| US-20050192232-A1 | Novel acyl-dipeptide-like compounds bearing an accessory functional side chain spacer, a method for preparing the same and pharmaceutical compositions containing such products | OM PHARMA (CH) | 2005-09-01 | — | — | US | claimed |
| US-20030203852-A1 | Acyl pseudodipeptides which carry a functionalised auxialiary arm | OM PHARMA (CH) | 2003-10-30 | — | — | US | claimed |
| CN-1434795-A | Acylated Pseudodipeptides with Functionalized Auxiliary Branches | OM PHARMA (CH) | 2003-08-06 | — | — | CN | claimed |
| US-10174132-B2 | Heparan sulfate synthesis | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2019-01-08 | — | — | US | disclosed |
| CN-107325127-A | The PSMA inhibitor of chelating | 癌靶技术有限责任公司 | 2017-11-07 | — | — | CN | disclosed |
| CN-103930432-B | Chelated PSMA Inhibitors | 癌靶技术有限责任公司 | 2017-06-23 | — | — | CN | disclosed |
| CN-106414473-A | Polyene macrolide derivative | 盐野义制药株式会社 | 2017-02-15 | — | — | CN | disclosed |
| US-20160060365-A1 | HEPARAN SULFATE SYNTHESIS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2016-03-03 | — | — | US | disclosed |
| US-8957205-B2 | Cycloalkane carboxamide derivatives and production process of same | SEIKAGAKU CORPORATION (JP) | 2015-02-17 | — | — | US | disclosed |
| US-8829209-B2 | Cycloalkylcarbonylamino acid ester derivative and process for producing the same | SEIKAGAKU CORPORATION (JP) | 2014-09-09 | — | — | US | disclosed |
| CN-101370773-B | Cycloalkanecarboxamide derivative and method for producing same | SEIKAGAKU KOGYO CO LTD | 2014-04-09 | — | — | CN | disclosed |
| CN-1185253-C | Novel glycoproteins | NOVARTIS AG (CH) | 2005-01-19 | — | — | CN | disclosed |
| US-20040132809-A1 | Cell adhesion inhibitors | BIOGEN, INC. | 2004-07-08 | — | — | US | disclosed |
| US-6630503-B1 | Non-peptidic sulfonamide compounds that specifically inhibit the binding of ligands to VLA-4 for inhibition, prevention and suppression of VLA-4-mediated cell adhesion and pathologies such as inflammation and immune reactions | BIOGEN, INC. | 2003-10-07 | — | — | US | disclosed |
| CN-1434795-A | Acylated Pseudodipeptides with Functionalized Auxiliary Branches | OM PHARMA (CH) | 2003-08-06 | — | — | CN | disclosed |
| CN-1082051-C | Novel cyclic depsipeptide PF1022 derivatives | MEIJI SEIKA CO (JP) | 2002-04-03 | — | — | CN | disclosed |
| CN-1252807-A | Novel glycoproteins | NOVARTIS AG (CH) | 2000-05-10 | — | — | CN | disclosed |
| CN-1201454-A | Meta-guanidino, ureido, thioureido or azacyclic aminobenzoic acid derivatives as integrin antagonists | SEARLE & CO (US) | 1998-12-09 | — | — | CN | disclosed |
| CN-1201456-A | Novel cyclic depsipeptide PF1022 derivatives | MEIJI SEIKA CO (JP) | 1998-12-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132809-A1 | Cell adhesion inhibitors | VCAM1, ICAM1, EPCAM | ALDH1A1 631/4885IDO1 4735/4885KMT2A 2350/4885 |
| US-20050192232-A1 | Novel acyl-dipeptide-like compounds bearing an accessory functional side chain spacer, a method for preparing the same and pharmaceutical compositions containing such products | PIGS, AADAT, CD74 | ALDH1A1 3553/4885IDO1 128/4885KMT2A 2277/4885 |
| US-20030203852-A1 | Acyl pseudodipeptides which carry a functionalised auxialiary arm | PIGS, AADAC, ENPP2 | ALDH1A1 4311/4885IDO1 248/4885KMT2A 1663/4885 |
| US-10174132-B2 | Heparan sulfate synthesis | HPSE, STT3B, DDOST | ALDH1A1 3615/4885IDO1 3390/4885KMT2A 2909/4885 |
| US-20160060365-A1 | HEPARAN SULFATE SYNTHESIS | HPSE, STT3B, DDOST | ALDH1A1 3615/4885IDO1 3390/4885KMT2A 2909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.